Electromed, Inc. (NASDAQ: ELMD), developer, manufacturer and distributor of the patented SmartVest® Airway Clearance System, today announced that its Chairman & CEO, Robert Hansen, along with members of the Company’s management team and Board of Directors, will preside over the NASDAQ closing bell ceremony on Tuesday, December 14, 2010. This event celebrates the Company's recent listing on the NASDAQ Capital Market. One of only two companies to successfully complete an IPO in Minnesota in 2010, Electromed, Inc.’s common stock began trading on the NASDAQ Capital Market on Thursday, August 13, 2010 under the trading symbol "ELMD."
The Closing Bell ceremony will take place at NASDAQ MarketSite in Times Square and will be broadcast live on financial cable channels and displayed on the seven-stories-tall MarketSite Tower. The ceremony can also be viewed in real-time on the Web starting at 3:45 p.m. (EST) at: http://www.nasdaq.com/about/marketsitetowervideo.asx
“Pneumonia continues as one of the major threats to human life,” said Robert Hansen, Chairman & CEO of Electromed, Inc. “Serving people who confront years of repeated lung infections and declining quality of life is our primary challenge. It is Electromed, Inc’s. mission to improve such persons’ lives by reducing the presence of secretions in their lungs, thereby eliminating a primary source of pneumonia, thus paving the way to fuller, happier, healthier lives. Today, I join the courageous shareholders, dedicated employees, and thousands of patients who are benefitting from the SmartVest® Airway Clearance System. This Company continues on a strong growth path, is conservatively financed and is led by people with great compassion and competence. We are honored that NASDAQ and its members can now discover us and grow with us into our exciting future.”
The Company’s reputation for achieving growth and product excellence, along with maintaining strong financial performance, has placed it in the Top 25 Medical Technology Companies in the Minneapolis/St. Paul metro area as reported by the Minneapolis/St. Paul Business Journal in July 2010.
About Electromed, Inc.
Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System and related products, to patients with compromised pulmonary function. The SmartVest® Airway Clearance System has been approved by the FDA to treat the condition of excess lung secretions. Consequently, it may be prescribed to patients suffering from cystic fibrosis, chronic obstructive pulmonary disease, muscular dystrophy, post-surgical airway complications, and a variety of other diseases and conditions associated with impaired lung and airway capacity. Electromed, Inc. has earned the Joint Commission’s Gold Seal of Approval, is ISO 13485/9001 certified, and has also been certified to apply the CE mark for sales in the European Union.